Asuragen Nets $3.8M in SBIR/STTR Grants

The firm will use the NIH grants to develop biomarkers, diagnostics, and microarray technologies.

Full-text access for registered users only. Existing users login here.
New to GenomeWeb? Register here quickly for free access.